Solifenacin succinate intermediates manufacturers
  • Home
  • Solifenacin succinate intermediates

Solifenacin succinate intermediates manufacturers

A.R Life Sciences are high-quality Solifenacin succinate intermediates manufacturers. Solifenacin is a medication utilized in the treatment of overactive bladder and neurogenic detrusor overactivity. It lasts for a long duration. It will assist with urinary incontinence, frequency, and urgency. Solifenacin acts on the muscarinic receptors and treats the overactive bladder. It acts in the same way as the medications in similar classes. It also acts on the detrusor muscle, to prevent its contraction.
We as Solifenacin succinate intermediates manufacturers, constantly work on developing the best products at competitive prices. We grew to be prominent in the pharmaceutical industry with our dedication and Innovation. We are ISO 9001:2015 certified organization, with GMP certification for our units and one of our units being approved by USFDA. All our intermediates are formulated following ICH standards. Our products are developed in a powdered format. We accept orders with a minimum quantity of 100 gms.

Solifenacin intermediate is a medicine used to treat overactive bladder and neurogenic detrusor overactivity. It may help with incontinence, urinary frequency, and urinary urgency. Benefits appear similar to other medications in the class

Pharmaceutical Intermediates

1193-65-3:

Solifenacin succinate intermediates manufacturers
  • Product Features
  • Advantages
  • Applications
  • Specifications
  • Form: Powder
  • Minimum order quantity: 100gram
  • Categories: Pharma intermediates, Pharma API, Pharmaceutical intermediates, Pharmaceutical API, Active Pharmaceutical Ingredients
  • Usage/Application: Commercial
  • Manufacturer: A. R. Life sciences Pvt Ltd.
  • Cancer (Bendamustine intermediates, Imatinib intermediates)
  • Cardiovascular (Clopidogrel bisulphate intermediate & API)
  • Anti-Coagulant (Dabigatran intermediates & API, CamostatMesylate intermediates & API)
  • Leukemia (Dasatinib intermediates)
  • Pain (Elagolix intermediate)
  • Gaucher disease (Eliglustat intermediates)
  • Osteoporosis (Ibandronate intermediate)
  • Cystic fibrosis (Ivacaftor intermediates)
  • Hyperuricemia (Lesinurad intermediate)
  • Urinary Incontinence (Mirabegron, Solifenacin intermediates)
  • Nausea & vomiting (Ondansetron intermediates)
  • Anti-Psychotic (Paliperidone/Risperidone, Quetiapine intermediates)
  • Acute Diarrhoea (Racecadotril intermediates)
  • Deep vein thrombosis (Rivaroxaban intermediate)
  • Type 2 Diabetes (Sitagliptin intermediates)
  • NSAID (Etodolac API)
  • Antibiotic (Sparfloxacin API)
  • Anti-Arrhythmic agent (Adenosine API)
  • Anti-Lipemic (Rosuvastatin calcium API)
  • Iron chelator (Deferasirox)
  • Purity, Grade

Solifenacin Succinate Intermediates Specifications :

Intermediate CAS No API/End Use
3-Quinuclidinone hydrochloride 1193-65-3 Solifenacin

Home / Solifenacin Intermediate / Cas no: 1193-65-3

Product Information Quinuclidin-3-one Hydrochloride
Product Name :
3-Quinuclidinone Hydrochloride
CAS No. :
1193-65-3
MDL No. :
MFCD00000442
Molecular Formula :
C7H11NO · HCl
Boiling Point :
240°C
Molecular Weight :
161.63
Purity/ Specification :
95%
Storage :
Inert atmosphere, Room Temperature
Cas no. 1193-65-3